WallStreetZenWallStreetZen

NASDAQ: PGEN
Precigen Inc Stock Ownership - Who owns Precigen?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Precigen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Harry Thomasian Jr.CFO2026-09-231$1.21
$1.21Buy
Harry Thomasian Jr.CFO2026-09-2310,744$4.72
$50.71kBuy
Harry Thomasian Jr.CFO2026-09-2342,918$2.33
$100.00kBuy
Harry Thomasian Jr.CFO2026-09-232$0.96
$1.92Buy
Jeffrey B. KindlerDirector2026-08-26185,000$7.44
$1.38MSell
Rutul R. ShahCOO2026-08-2515,342$7.50
$115.07kSell
Phil TennantCCO2026-08-2579,166$7.50
$593.75kSell
Phil TennantCCO2026-08-2579,166$1.61
$127.46kBuy
Rutul R. ShahCOO2026-08-2515,342$2.33
$35.75kBuy
Phil TennantCCO2026-08-232,585$7.20
$18.61kSell

1 of 7

PGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PGEN insiders and whales buy or sell their stock.

PGEN Shareholders

What type of owners hold Precigen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk72.22%258,555,888$1.72BInsider
Trading Sa Ares5.77%20,647,152$137.10MInsider
Helen Sabzevari1.06%3,779,521$25.10MInsider
Fred Hassan0.35%1,243,239$8.26MInsider
Steven Frank0.34%1,226,391$8.14MInsider
Cesar L. Alvarez0.22%782,909$5.20MInsider
Donald P. Lehr0.21%758,181$5.03MInsider
Jeffrey Thomas Perez0.21%743,097$4.93MInsider
James S. Turley0.19%685,417$4.55MInsider
Vinita D. Gupta0.19%669,027$4.44MInsider

1 of 3

PGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PGEN0.04%81.77%Net SellingNet Selling
ZLAB0.00%1.78%Net BuyingNet Selling
ADMA0.09%25.11%Net Selling
NAMS0.10%34.84%Net SellingNet Selling
CLDX0.11%16.22%Net Buying
View Top Biotech Stocks

Precigen Stock Ownership FAQ

Who owns Precigen?

Precigen (NASDAQ: PGEN) is owned by 0.04% institutional shareholders, 81.77% Precigen insiders, and 18.19% retail investors. Randal J. Kirk is the largest individual Precigen shareholder, owning 258.56M shares representing 72.22% of the company. Randal J. Kirk's Precigen shares are currently valued at $1.79B.

If you're new to stock investing, here's how to buy Precigen stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.